Trelegy Ellipta 100/62.5/25Mcg Inh 30D

DRUG2 trials

Sponsors

Pulmonary Research Institute of Southeast Michigan, Fundacio Privada Mon Clinic Barcelona

Conditions

COPDChronic Obstructive Pulmonary Disease

Phase 4

Peak Inspiratory Flow and Dry Powder Inhaler Performance in COPD

CompletedNCT04606394

Pulmonary Research Institute of Southeast MichiganCOPD

Start: 2020-12-02End: 2021-12-15Updated: 2023-05-08

ANTES B+ Clinical Trial

TerminatedNCT06282861

Fundacio Privada Mon Clinic BarcelonaChronic Obstructive Pulmonary Disease

Start: 2024-02-29End: 2025-01-23Updated: 2025-08-14

Related Papers

Assessment of peak inspiratory flow in patients with chronic obstructive pulmonary disease: a multicentre, observational, prospective, real-life study

BMJ Open Respiratory Research2025-09-01